Citations

Showing 10 of 108094 citations.

Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain
Nation, Kelsey , Felice, Milena De , Neugebauer, Volker , Navratilova, Edita , Nation, Kelsey M , Hernandez, Pablo I., Dodick, David W. , Porreca, Frank

Mayo Clinic

Pain | January 25, 2018 | Volume: 159 | Issue: 5 | Pages: 919-928

10.1097/j.pain.0000000000001167 | PMID 29369967 Get It

AbstractThe response of diffuse noxious inhibitory controls (DNIC) is often decreased, or lost, in stress-related functional pain syndromes. Because the dynorphin/kappa opioid receptor (KOR) pathway is activated by stress, we determined its role in DNIC using a model of stress-induced functional pain. Male, Sprague-Dawley rats were primed for 7 days with systemic morphine resulting in opioid-induced hyperalgesia. Fourteen days after priming, when hyperalgesia was resolved, rats were exposed to environmental stress and DNIC was evaluated by measuring hind paw response threshold to noxious pressure (test stimulus) after capsaicin injection in the forepaw (conditioning stimulus). Morphine priming without stress did not alter DNIC. However, stress produced a loss of DNIC in morphine-primed rats in both hind paws that was abolished by systemic administration of the KOR antagonist, nor-binaltorphimine (nor-BNI). Microinjection of nor-BNI into the right, but not left, central nucleus of the amygdala (CeA) prevented the loss of DNIC in morphine-primed rats. Diffuse noxious inhibitory controls were not modulated by bilateral nor-BNI in the rostral ventromedial medulla. Stress increased dynorphin content in both the left and right CeA of primed rats, reaching significance only in the right CeA; no change was observed in the rostral ventromedial medulla or hypothalamus. Although morphine priming alone is not sufficient to influence DNIC, it establishes a state of latent sensitization that amplifies the consequences of stress. After priming, stress-induced dynorphin/KOR signaling from the right CeA inhibits DNIC in both hind paws, likely reflecting enhanced descending facilitation that masks descending inhibition. Kappa opioid receptor antagonists may provide a new therapeutic strategy for stress-related functional pain disorders.
Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state
Post, Robert M. , Leverich, Gabriele S., Kupka, Ralph , Suppes, Trisha , Altshuler, Lori L., Nolen, Willem A. , Frye, Mark A. , Keck, Paul E., Grunze, Heinz , Hellemann, Gerhard , Frye, Mark, Grunze, Heinz , McElroy, Susan L.

Mayo Clinic

Bipolar Disorders | January 25, 2018 | Volume: 20 | Issue: 4 | Pages: 303-312

10.1111/bdi.12596 | PMID 29369448 Get It

AbstractObjectivesA high incidence of Axis II personality disorders is described in patients with bipolar disorder; however, their relationship to mood state remains uncertain.MethodsA total of 966 outpatients with bipolar disorder gave informed consent and filled out the Personality Disorder Questionnaire, 4th edition (PDQ4) and a questionnaire on demographics and course of illness prior to Bipolar Treatment Outcome Network entry at average age 41 years. Patients were rated at each visit for depression on the Inventory of Depressive Symptoms‐Clinician version (IDS‐C) and for mania on the Young Mania Rating Scale (YMRS). In a subgroup, the PDQ4 was retaken during periods of depression and euthymia.ResultsPatients met criteria for most personality disorders at a much higher rate when they took the PDQ4 while depressed compared to while euthymic, and scores were significantly related to the severity of depression (IDS) and of mania (YMRS) assessed within 2 weeks of taking the PDQ. Even when euthymic, more than quarter to half of the patients met criteria for a cluster A, B or C personality disorder.ConclusionsA wide range of personality disorders occur in bipolar patients, but are highly dependent on filling out the form while depressed compared to while euthymic. How this relates to having a personality disorder assessed using a structured clinical interview remains to be tested. However, higher PDQ4 scores are related to an earlier age of onset of bipolar disorder and other factors portending a more difficult course of bipolar disorder, and the optimal treatment of these patients remains to be illuminated.
Practical Implementation of Failure Mode and Effects Analysis for Extracorporeal Membrane Oxygenation Activation
Nasim, Faria, Poterucha, Joseph T., Daniels, Lisa M. , Park, John G. , Seelhammer, Troy G. , Bohman, J. Kyle , Friedrich, Tammy, Blau, Caitlin, Elmer, Jennifer, Schears, Gregory J. , Bohman, John K., Friedrich, Tammy P, Blau, Caitlin L, Elmer, Jennifer L, Bohman, John K

Mayo Clinic

American Journal of Medical Quality | January 25, 2018 | Volume: 33 | Issue: 5 | Pages: 523-529

10.1177/1062860618754703 | PMID 29366330 Get It

Extracorporeal membrane oxygenation (ECMO) is used to treat severe hypoxemic respiratory failure and as a rescue therapy for patients with cardiopulmonary arrest within a narrow window of time. A failure modes and effects analysis (FMEA) was conducted to analyze the clinical and operational processes leading to delays in initiating ECMO. FMEA determined these highest-risk failure modes that were contributing to process failure: (1) ECMO candidacy not determined in time, (2) no or incomplete evaluation for ECMO prior to consult or arrest, (3) ECMO team not immediately available, and (4) cannulation not completed in time. When implemented collectively, a total of 4 interventions addressed more than 95% of the system failures. These interventions were (1) ECMO response pager held by a team required for decision, (2) distribution of institutionally defined inclusion/exclusion criteria, (3) educational training for clinicians consulting the ECMO team, and (4) establishment of a mobile ECMO insertion cart.
Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca 2+ homeostasis under metabolic stress
Jovanovi, Nenad, Jovanovi, Sofija, Jovanovi, Aleksandar, Terzic, André

Mayo Clinic

The FASEB Journal | January 25, 2018 | Volume: 13 | Issue: 8 | Pages: 923-929

10.1096/fasebj.13.8.923 | PMID 10224235 Get It

ABSTRACT Metabolic injury is a complex process affecting various tissues, with intracellular Ca 2+ loading recognized as a common precipitating event leading to cell death. We have recently observed that cells overexpressing recombinant ATP‐sensitive K + (K ATP ) channel subunits may acquire resistance against metabolic stress. To examine whether, under metabolic challenge, intracellular Ca 2+ homeostasis can be maintained by an activator of channel proteins, we delivered Kir6.2 and SUR2A genes, which encode K ATP channel subunits, into a somatic cell line lacking native K ATP channels. Hypoxia‐reoxygenation was simulated by application and removal of the mitochondrial poison 2,4 dinitrophenol. Under such metabolic stress, Ca 2+ loading was induced by Ca 2+ influx during hypoxia and release of Ca 2+ from intracellular stores during reoxygenation. Delivery of Kir6.2/SUR2A genes, in conjunction with the K ATP channel activator pinacidil, prevented intracellular Ca 2+ loading irrespective of whether the channel opener was applied throughout the duration of hypoxia‐reoxygenation or transiently during the hypoxic or reoxygenation stage. In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K ATP channel, 5‐hydroxydecanoate. The present study provides evidence that combined use of gene delivery and pharmacological targeting of recombinant proteins can handle intracellular Ca 2+ homeostasis under hypoxia‐reoxygenation irrespective of the stage of the metabolic insult.—Jovanović, N., Jovanović, S., Jovanović, A., Terzic, A. Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca 2+ homeostasis under metabolic stress. FASEB J. 13, 923–929 (1999)
Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea
Zhang, Wei , Mannan, Ishrat, Schulz, Stephanie, Parkinson, Scott J., Alekseev, Alexey E., Gómez, Luis Alberto , Terzic, André , Waldman, Scott A.

Mayo Clinic

The FASEB Journal | January 25, 2018 | Volume: 13 | Issue: 8 | Pages: 913-922

10.1096/fasebj.13.8.913 | PMID 10224234 Get It

ABSTRACT Bacteria that produce heat‐stable enterotoxins (STs), a leading cause of secretory diarrhea, are a major cause of morbidity and mortality worldwide. ST stimulates guanylyl cyclase C (GCC) and accumulation of intracellular cyclic GMP ([cGMP] i ), which opens the cystic fibrosis transmembrane conductance regulator (CFTR)‐related chloride channel, triggering intestinal secretion. Although the signaling cascade mediating ST‐induced diarrhea is well characterized, antisecretory therapy targeting this pathway has not been developed. 2‐ChloroATP (2ClATP) and its cell‐permeant precursor, 2‐chloroadenosine (2ClAdo), disrupt ST‐dependent signaling in intestinal cells. However, whether the ability to disrupt guanylyl cyclase signaling translates into effective antisecretory therapy remains untested. In this study, the efficacy of 2ClAdo to prevent ST‐induced water secretion by human intestinal cells was examined. In Caco‐2 human intestinal cells, ST increased [cGMP] i , induced a chloride current, and stimulated net basolateral‐to‐apical water secretion. This effect on chloride current and water secretion was mimicked by the cell‐permeant analog of cGMP, 8‐bromo‐cGMP. Treatment of Caco‐2 cells with 2ClAdo prevented ST‐induced increases in [cGMP] i , chloride current and water secretion. Inhibition of the downstream consequences of ST‐GCC interaction reflects proximal disruption of cGMP production because 8‐bromo‐cGMP stimulated chloride current and water secretion in 2ClAdo‐treated cells. Thus, this study demonstrates that disruption of guanylyl cyclase signaling is an effective strategy for antisecretory therapy and provides the basis for developing mechanism‐based treatments for enterotoxigenic diarrhea.—Zhang, W., Mannan, I., Schulz, S., Parkinson, S. J., Alekseev, A. E., Gomez, L. A., Terzic, A., Waldman, S. A. Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea. FASEB J. 13, 913–922 (1999)
Participation of dynamin in the biogenesis of cytoplasmic vesicles
Henley, John R. , Cao, Hong , McNiven, Mark A.

Mayo Clinic

The FASEB Journal | January 25, 2018 | Volume: 13 | Issue: 9002 | Pages: No page available

10.1096/fasebj.13.9002.s243 | PMID 10619136 Get It

ABSTRACT Dynamin is a 100‐kDa GTPase that has been implicated in endocytosis. To extend our understanding of its cellular functions, we have microinjected specific affinity‐purified anti‐dynamin antibodies into cultured mammalian epithelial cells. Using this approach, dynamin function can be inhibited specifically and rapidly in single cells. Effects of microinjected inhibitory antibodies on distinct endocytic processes and plasmalemmal morphology were then assayed by fluorescence microscopy (FM) and ultrastructural analysis. Microinjected antibodies inhibit the clathrin‐mediated endocytosis of fluorophore‐labeled transferrin and cause a marked invagination of the plasma membrane. Many of these long plasmalemmal invaginations had clathrin‐coated pits along their cytoplasmic surface. A number of distinct noncoated pits resembling plasmalemmal caveolae also accumulated in anti‐dynamin antibody‐injected cells. Further, the cellular uptake of cholera toxin B, which normally occurs by the internalization of caveolae, was inhibited in these cells. In support of these observations, immunoisolation techniques, double‐label immuno‐FM, and immunoelectron microscopy (immuno‐EM) provided biochemical and morphological evidence that dynamin associates with plasmalemmal caveolae. Together, these observations indicate that dynamin mediates scission from the plasma membrane of both clathrincoated pits and caveolae during distinct endocytic processes. These results demonstrate that dynamin isoforms are involved in an additional endocytic process that is distinct from clathrinmediated endocytosis and provide significant insights into the molecular mechanisms governing the GTP‐mediated internalization of caveolae. Evidence is provided demonstrating that dynamin isoforms have a differential distribution in mammalian cells. Targeting information for these isoforms is provided at least in part by regions of alternative splicing. Thus, the different dynamin isoforms may be localized to distinct cellular compartments but provide a similar scission function during the biogenesis of nascent cytoplasmic vesicles—Henley, J. R., Cao, H., McNiven, M. A. Participation of dynamin in the biogenesis of cytoplasmic vesicles. FASEB J. 13 (Suppl.), S243‐S247 (1999)
Phosphotransfer reactions in the regulation of ATP‐sensitive K + channels
Dzeja, Petras P. , Terzic, André

Mayo Clinic

The FASEB Journal | January 25, 2018 | Volume: 12 | Issue: 7 | Pages: 523-529

10.1096/fasebj.12.7.523 | PMID 9576479 Get It

ATP‐sensitive K + (K ATP ) channels are nucleotide‐gated channels that couple the metabolic status of a cell with membrane excitability and regulate a number of cellular functions, including hormone secretion and cardioprotection. Although intracellular ATP is the endogenous inhibitor of K ATP channels and ADP serves as the channel activator, it is still a matter of debate whether changes in the intracellular concentrations of ATP, ADP, and/or in the ATP/ADP ratio could account for the transition from the ATP‐liganded to the ADP‐liganded channel state. Here, we overview evidence for the role of cellular phosphotransfer cascades in the regulation of K ATP channels. The microenvironment of the K ATP channel harbors several phosphotransfer enzymes, including adenylate, creatine, and pyruvate kinases, as well as other glycolytic enzymes that are able to transfer phosphoryls between ATP and ADP in the absence of major changes in cytosolic levels of adenine nucleotides. These phosphotransfer reactions are governed by the metabolic status of a cell, and their phosphotransfer rate closely correlates with K ATP channel activity. Adenylate kinase catalysis accelerates the transition from ATP to ADP, leading to K ATP channel opening, while phosphotransfers driven by creatine and pyruvate kinases promote ADP to ATP transition and channel closure. Thus, through delivery and removal of adenine nucleotides at the channel site, phosphotransfer reactions could regulate ATP/ADP balance in the immediate vicinity of the channel and thereby the probability of K ATP channel opening. In this way, phosphotransfer reactions could provide a transduction mechanism coupling cellular metabolic signals with K ATP channel‐associated functions.
Channelopathies of inwardly rectifying potassium channels
Abraham, M. Roselle , Alekseev, Alexey E., Jahangir, Arshad , Terzic, André

Mayo Clinic

The FASEB Journal | January 25, 2018 | Volume: 13 | Issue: 14 | Pages: 1901-1910

10.1096/fasebj.13.14.1901 | PMID 10544173 Get It

ABSTRACT Mutations in genes encoding ion channels have increasingly been identified to cause disease conditions collectively termed channelopathies. Recognizing the molecular basis of an ion channel disease has provided new opportunities for screening, early diagnosis, and therapy of such conditions. This synopsis provides an overview of progress in the identification of molecular defects in inwardly rectifying potassium (Kir) channels. Structurally and functionally distinct from other channel families, Kir channels are ubiquitously expressed and serve functions as diverse as regulation of resting membrane potential, maintenance of K + homeostasis, control of heart rate, and hormone secretion. In humans, persistent hyperinsulinemic hypoglycemia of infancy, a disorder affecting the function of pancreatic β cells, and Bartter's syndrome, characterized by hypokalemic alkalosis, hypercalciuria, increased serum aldosterone, and plasma renin activity, are the two major diseases linked so far to mutations in a Kir channel or associated protein. In addition, the weaver phenotype, a neurological disorder in mice, has also been associated with mutations in a Kir channel subtype. Further genetic linkage analysis and full understanding of the consequence that a defect in a Kir channel would have on disease pathogenesis are among the priorities in this emerging field of molecular medicine.—Abraham, M. R., Jahangir, A., Alekseev, A. E., Terzic, A. Channelopathies of inwardly rectifying potassium channels. FASEB J . 13, 1901–1910 (1999)
Medial Patellofemoral Ligament Reconstruction Reduces Radiographic Measures of Patella Alta in Adults
Johnson, Nick R., Cates, Robert A. , Krych, Aaron J. , Dahm, Diane L., Woodmass, Jarret M, Krych, Aaron J , Woodmass, Jarret Murray , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | January 25, 2018 | Volume: 6 | Issue: 1 | Pages: No page available

10.1177/2325967117751659 | PMID 29399590 Get It

Background: Patellar height has long been considered a risk factor for patellofemoral instability. However, recent pediatric literature demonstrated a reduction in patellar height measurements following medial patellofemoral ligament (MPFL) reconstruction. Purpose: To assess the mean change in patellar height and the percentage of skeletally mature patients with patellar height ratios reduced to within-normal limits following MPFL reconstruction. Study Design: Case series; Level of evidence, 4. Methods: Adult patients undergoing primary MPFL reconstruction for recurrent lateral patellar instability between 2005 and 2013 were identified. Pre- and postoperative (within 1 year of surgery) lateral knee radiographs were assessed for patellar height indices, including Caton-Deschamps, Blackburne-Peel, and Insall-Salvati ratios. The change in patellar height and the number of patients reduced from abnormal to normal patellar height ratios following MPFL reconstruction were assessed. Results: Overall, 32 adult patients were included in the study, with a mean age of 25.7 years (range, 18-55 years). There were 21 women (66%) and 11 men (34%). Insall-Salvati, Blackburne-Peel, and Caton-Deschamps ratios all demonstrated significant reductions in patellar height between pre- and postoperative lateral knee radiographs ( P < .001). All 3 indices showed a reduction in the number of patients meeting the criteria for patella alta following MPFL reconstruction. A total of 64% of patients had an abnormal preoperative Caton-Deschamps ratio reduced to within normal limits postoperatively. Conclusion: MPFL reconstruction provides a consistent reduction in patellar height measurements. The Caton-Deschamps ratio was reduced to the reference range following MPFL reconstruction in 64% of patients with preoperative patella alta. Surgeons treating patellofemoral instability should expect a reduction in patellar height after ligament reconstruction, which may affect the need for more invasive distalization procedures.